<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29898151</article-id><article-id pub-id-type="pmc">5985848</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0144</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Percutaneous Lead Extraction in Infection of Cardiac Implantable
Electronic Devices: a Systematic Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Menezes J&#x000fa;nior</surname><given-names>Ant&#x000f4;nio da Silva</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Magalh&#x000e3;es</surname><given-names>Tha&#x000ed;s Rodrigues</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Morais</surname><given-names>Alana de Oliveira Alarc&#x000e3;o</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD </role></contrib><aff id="aff1"><label>1</label> Escola de Ci&#x000ea;ncias M&#x000e9;dicas,
Farmac&#x000ea;uticas e Biom&#x000e9;dicas of the Pontif&#x000ed;cia Universidade
Cat&#x000f3;lica de Goi&#x000e1;s (PUC-GO), Goi&#x000e2;nia, GO, Brazil.</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: Ant&#x000f4;nio da Silva Menezes
J&#x000fa;nior, Pontif&#x000ed;cia Universidade Cat&#x000f3;lica de Goi&#x000e1;s -
Escola de Ci&#x000ea;ncias, Av. Universit&#x000e1;ria, s/n - Setor
Universit&#x000e1;rio - Goi&#x000e2;nia, GO, Brazil, Zip code: 74605-010. E-mail:
<email>a.menezes.junior@uol.com.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2018</year></pub-date><volume>33</volume><issue>2</issue><fpage>194</fpage><lpage>202</lpage><history><date date-type="received"><day>13</day><month>7</month><year>2017</year></date><date date-type="accepted"><day>22</day><month>8</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>In the last two decades, the increased number of implants of cardiac
implantable electronic devices has been accompanied by an increase in
complications, especially infection. Current recommendations for the
appropriate treatment of cardiac implantable electronic devices-related
infections consist of prolonged antibiotic therapy associated with complete
device extraction. The purpose of this study was to analyze the importance
of percutaneous extraction in the treatment of these devices infections.</p></sec><sec><title>Methods</title><p>A systematic review search was performed in the PubMed, BVS, Cochrane
CENTRAL, CAPES, SciELO and ScienceDirect databases. A total of 1,717 studies
were identified and subsequently selected according to the eligibility
criteria defined by relevance tests by two authors working
independently.</p></sec><sec><title>Results</title><p>Sixteen studies, describing a total of 3,354 patients, were selected.
Percutaneous extraction was performed in 3,081 patients. The average success
rate for the complete percutaneous removal of infected devices was 92.4%.
Regarding the procedure, the incidence of major complications was 2.9%, and
the incidence of minor complications was 8.4%. The average in-hospital
mortality of the patients was 5.4%, and the mortality related to the
procedure ranged from 0.4 to 3.6%. The mean mortality was 20% after 6 months
and 14% after a one-year follow-up.</p></sec><sec><title>Conclusion</title><p>Percutaneous extraction is the main technique for the removal of infected
cardiac implantable electronic devices, and it presents low rates of
complications and mortality related to the procedure.</p></sec></abstract><kwd-group><kwd>Infection</kwd><kwd>Review Literature as Topic</kwd><kwd>Review</kwd><kwd>Cardiac Resynchronization Therapy Devices</kwd><kwd>Device Removal/Methods</kwd></kwd-group></article-meta></front><body><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">BVS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Biblioteca Virtual em
Sa&#x000fa;de</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CENTRAL</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cochrane Register of
Controlled Trials</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Confidence Interval</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CIED</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiac Implantable
Electronic Devices</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">DMP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Data Management
Platform</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Implantable
Cardioverter-defibrillator</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MeSH Terms</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Medical Subject Headings
Terms</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PRISMA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Preferred Reporting
Items for Systematic Reviews and Meta-Analyses</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PubMed</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= US National Library of
Medicine</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SciELO</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Scientific Electronic
Library Online</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">VHL</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Virtual Health
Library</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>In the last two decades, the number of cardiac implantable electronic devices (CIED)
has increased. CIED complications, of which infection is among the most important,
have also increased. In the United States, 2.9 million patients had a permanent
pacemaker between 1993 and 2009, which represents an increase in pacemaker use of
55.6% during this period<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. At the same time, there was a 210% increase in CIED
infections, which is alarming because these infections represent a serious and
costly complication for the health care system<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. In a large population study, the
incidence of CIED-related infection was estimated at 1.82 for each 1,000 implanted
devices per year between 1982 and 2007<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p><p>The appropriate treatment of CIED-related infections is the administration of
prolonged antibiotic therapy associated with complete device extraction. The
importance of removing the device was evidenced after an analysis of infected leads,
which demonstrated that bacteria coated the leads and formed a "biofilm", making the
infection resistant to antibiotics<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Thus, non-removal of the device is associated
with an increased risk of infection recurrence and device-related endocarditis, in
addition to increased patient mortality<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>There are two types of procedures for the removal of leads: surgical removal and
percutaneous extraction. Surgical removal is performed by thoracotomy and
extracorporeal circulation and presents a high mortality rate, ranging from 12.5% to
21%; it is mainly reserved for cases requiring repair of valve injury, large
vegetations or failure after percutaneous attempt. When comparing aspects of the
percutaneous removal and surgical removal, it is imperative to consider that the
complications of surgical removal usually relate to the more severe patients
selection, large vegetations, abscesses, including cases of septicemia, or even
cases of complication in the attempt of percutaneous extraction. On the other hand,
percutaneous extraction has been indiscriminately used in uncountable cases with
uninfected leads in patients with an inferior profile concerning the procedure's
risk<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>Infection related to intracardiac devices significantly increases morbidity and
mortality rates as well as the costs for health services and the length of hospital
stay<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.
Although evidence shows that adequate treatment of these infections consists of
antibiotic therapy associated with CIED removal, preferably by percutaneous
extraction, several treatment aspects remain uncertain in the literature. This
review aims to analyze the importance of percutaneous lead extraction in the
treatment of CIED infections.</p></sec><sec sec-type="methods"><title>METHODS</title><p>A systematic review was conducted on lead extraction in the treatment of CIED-related
infections. The review followed the guidelines defined by the UK Cochrane Center in
an effort to reduce bias and provide reliable results<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>The search for the studies was conducted in the following databases: PubMed (US
National Library of Medicine), Biblioteca Virtual em Sa&#x000fa;de [BVS; Virtual
Health Library (VHL)], Cochrane Central Register of Controlled Trials (CENTRAL),
Portal de Peri&#x000f3;dicos CAPES (Portal of Journals CAPES), SciELO (Scientific
Electronic Library Online) and ScienceDirect (Elsevier Science).</p><p>Regarding the search for articles, search filters specific to each database that were
validated by the Cochrane Collaboration with a combination of terms using Boolean
operators ("AND" and "OR") were used. <xref ref-type="table" rid="t1">Table 1</xref>
provides an overview of the search strategies and the number of identified articles
according to the descriptors and terms defined in the different databases.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Search strategy and results found in databases.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="10%" span="1"/><col width="80%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Databases</th><th align="center" rowspan="1" colspan="1">Terms used / Search strategy</th><th align="center" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">PubMed</td><td align="left" rowspan="1" colspan="1">((("pacemaker, artificial"[MeSH Terms] OR
("pacemaker"[All Fields] AND "artificial"[All Fields]) OR
"artificial pacemaker"[All Fields] OR ("pacemaker"[All Fields] AND
"artificial"[All Fields]) OR "pacemaker, artificial"[All Fields]) OR
(("cardiovascular system"[MeSH Terms] OR ("cardiovascular"[All
Fields] AND "system"[All Fields]) OR "cardiovascular system"[All
Fields] OR "cardiovascular"[All Fields]) AND "implantable"[All
Fields] AND ("electronics"[MeSH Terms] OR "electronics"[All Fields]
OR "electronic"[All Fields]) AND ("equipment and supplies"[MeSH
Terms] OR ("equipment"[All Fields] AND "supplies"[All Fields]) OR
"equipment and supplies"[All Fields] OR "device"[All Fields]))) AND
"infection/therapy"[Mesh Terms]) AND ((("lead"[MeSH Terms] OR
"lead"[All Fields]) AND "extraction"[All Fields]) OR
"extraction"[All Fields] OR ("transvenous"[All Fields] AND
("lead"[MeSH Terms] OR "lead"[All Fields]) AND "extraction"[All
Fields]) OR ("device removal"[MeSH Terms] OR ("device"[All Fields]
AND "removal"[All Fields]) OR "device removal"[All Fields]))</td><td align="center" rowspan="1" colspan="1">232</td></tr><tr><td align="center" rowspan="1" colspan="1">BVS</td><td align="left" rowspan="1" colspan="1">(tw:(marcapasso artificial card&#x000ed;aco OR
marca-passo artificial OR pacemaker, artificial)) AND
(tw:(infec&#x000e7;&#x000e3;o OR infection)) AND
(tw:(remo&#x000e7;&#x000e3;o de dispositivo OR device removal OR
extraction)) AND (instance:"regional") (tw:(pacemaker, artificial OR
cardiovascular implantable electronic device OR marcapasso
card&#x000ed;aco artificial OR marca-passo artificial)) AND
(tw:(infection OR infec&#x000e7;&#x000e3;o)) AND (tw:(lead extraction
OR extraction OR device removal OR remo&#x000e7;&#x000e3;o de
dispositivo)) AND (instance:"regional")&#x000a0;</td><td align="center" rowspan="1" colspan="1">229</td></tr><tr><td align="center" rowspan="1" colspan="1">CENTRAL</td><td align="left" rowspan="1" colspan="1">("cardiovascular implantable electronic device
infection" OR "pacemaker infection") AND ("lead extraction" OR "lead
removal" OR "device removal")</td><td align="center" rowspan="1" colspan="1">124</td></tr><tr><td align="center" rowspan="1" colspan="1">CAPES</td><td align="left" rowspan="1" colspan="1">("pacemaker artificial infection" OR "cardiovascular
implantable electronic device infection") AND ("lead extraction" OR
"device removal")</td><td align="center" rowspan="1" colspan="1">776</td></tr><tr><td align="center" rowspan="1" colspan="1">SciELO</td><td align="left" rowspan="1" colspan="1">(pacemaker infection) AND (lead extraction) OR
(pacemaker infection treatment) (cardiovascular implantable
electronic device) OR (pacemaker) AND (infection) AND (lead
extraction)</td><td align="center" rowspan="1" colspan="1">21</td></tr><tr><td align="center" rowspan="1" colspan="1">ScienceDirect</td><td align="left" rowspan="1" colspan="1">(pacemaker infection OR cardiovascular implantable
electronic device infection) AND (lead extraction OR transvenous
lead extraction OR extraction OR treatment OR management)</td><td align="center" rowspan="1" colspan="1">335</td></tr></tbody></table></table-wrap><p>The search was carried out in August 2016. Initially, the studies were screened by an
exploratory reading of the title and abstract by the two researchers, acting
independently. The criteria for initial inclusion of the studies were delimited by
Relevance Test I, namely: (1) primary studies, except for case reports; (2) approach
for percutaneous lead extraction in cardiac implantable electronic device
infections; (3) age 18 years and over; (4) articles published in English or
Portuguese; (5) articles published between 2009 and 2016, as 2009 was the year of
publication of a consensus of the Heart Rhythm Society approved by the American
Heart Association, which unified the opinions and disagreements regarding the
indications for device extraction, highlighting infection as one of the three major
categories<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>.</p><p>After the initial screening, duplicates of the articles were removed, and the
complete text of each article was read. In this second phase, the articles were
selected through Relevance Test II, in which the research problem, objectives,
methodology and results of each study were analyzed in more detail to evaluate the
quality of the selected study and to classify it as relevant or not to the
review.</p><p>The studies were independently selected by two reviewers. Disagreements were resolved
by consensus, and if this was not possible, they were resolved based on the decision
of a third reviewer. Finally, the extracted data were interpreted and grouped in
tables in order to facilitate comparative analysis of the articles and
identification of the differences among them. The report of the systematic review
was guided using the PRISMA (Preferred Reporting Items for Systematic Reviews and
Meta-Analyses) checklist<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.</p><p>Data were analyzed using RevMan 5.0 statistical software provided by Cochrane
Collaboration. DMP and 95% CI were used as summary estimates. The presence of
heterogeneity among the studies was tested with the &#x003c7;<sup>2</sup>
heterogeneity test and the I<sup>2</sup> statistic. Heterogeneity was significant
when <italic>P</italic>&#x0003c;0.05 or I<sup>2</sup> was greater than 50%. A random
effects model was used in all analyzes to test the stability of the results at the
choice of the statistical model. If there is significant heterogeneity, the results
of the random effects model are used. A priori sensitivity analysis of high quality
studies for each clinical outcome was performed. The potential for publication bias
was evaluated using the funnel chart approach.</p></sec><sec sec-type="results"><title>RESULTS</title><p>Initially, 1,717 articles were identified by searching the research databases. Of
these, after exclusion of the repeated studies that were indexed in more than one
database and after the application of Relevance Test I, 57 articles were selected.
Subsequently, Relevance Test II was applied, delimiting the final selection of 16
articles. In <xref ref-type="fig" rid="f1">Figure 1</xref>, a diagram depicts the
selections and the reasons for exclusion of the articles.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flowchart of the systematic literature search in databases and of study
selection.</p></caption><graphic xlink:href="rbccv-33-02-0194-g01"/></fig>
</p><p>Following the literature search, 16 studies were included in this review, and their
main characteristics are presented in <xref ref-type="table" rid="t2">Tables
2</xref> and <xref ref-type="table" rid="t3">3</xref>. Regarding the study
method, 14 of the 16 studies performed retrospective analyses of the data recorded
from patients with CIED-related infection in a given period of time. Only two
references, Amraoui et al.<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup> and Deharo et al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>, consisted of
prospective studies. In addition, the articles by Deharo et
al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>, Rickard et al.<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup> and Cengiz et
al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>
compared their results to a control group of patients with intracardiac devices but
with no history of infection.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Demographic characteristics and comorbidities of the patients and clinical
presentation of the infection.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="80%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics of patients and clinical
presentation</th><th align="center" rowspan="1" colspan="1">Number of patients</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">67.8 (58-73)</td></tr><tr><td align="left" rowspan="1" colspan="1">Comorbidities</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Coronary artery disease</td><td align="center" rowspan="1" colspan="1">888</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Hypertension</td><td align="center" rowspan="1" colspan="1">802</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">537</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Heart failure</td><td align="center" rowspan="1" colspan="1">590</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Chronic renal failure</td><td align="center" rowspan="1" colspan="1">483</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Atrial fibrillation</td><td align="center" rowspan="1" colspan="1">438</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Chronic obstructive pulmonary disease</td><td align="center" rowspan="1" colspan="1">172</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Immune suppression/corticosteroid</td><td align="center" rowspan="1" colspan="1">174</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Malignancy</td><td align="center" rowspan="1" colspan="1">51</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Use of anticoagulants</td><td align="center" rowspan="1" colspan="1">85</td></tr><tr><td align="left" rowspan="1" colspan="1">Signs / symptoms of local infection</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Purulent drainage</td><td align="center" rowspan="1" colspan="1">372</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Erythema</td><td align="center" rowspan="1" colspan="1">347</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Pain</td><td align="center" rowspan="1" colspan="1">270</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Swelling</td><td align="center" rowspan="1" colspan="1">267</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Warmth</td><td align="center" rowspan="1" colspan="1">197</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Skin ulceration</td><td align="center" rowspan="1" colspan="1">113</td></tr><tr><td align="left" rowspan="1" colspan="1">Signs/symptoms of systemic infection</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Fever</td><td align="center" rowspan="1" colspan="1">628</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Chills</td><td align="center" rowspan="1" colspan="1">280</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Malaise</td><td align="center" rowspan="1" colspan="1">115</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Signs of sepsis</td><td align="center" rowspan="1" colspan="1">127</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Fatigue</td><td align="center" rowspan="1" colspan="1">27</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Anorexia</td><td align="center" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Nausea</td><td align="center" rowspan="1" colspan="1">8</td></tr><tr><td align="left" rowspan="1" colspan="1">Endocarditis/vegetation</td><td align="center" rowspan="1" colspan="1">1029</td></tr><tr><td align="left" rowspan="1" colspan="1">Devices</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Pacemaker</td><td align="center" rowspan="1" colspan="1">1745</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;ICD</td><td align="center" rowspan="1" colspan="1">819</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Biventricular</td><td align="center" rowspan="1" colspan="1">380</td></tr></tbody></table></table-wrap><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Characteristics of selected studies in relation to device extraction and
in-hospital and long-term mortality.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Author</th><th align="center" rowspan="1" colspan="1">Patients (number)</th><th align="center" rowspan="1" colspan="1">Method of extraction of intracardiac devices</th><th align="center" rowspan="1" colspan="1">Complications related to extraction (%)</th><th align="center" rowspan="1" colspan="1">Mortality during hospitalization (%)</th><th align="center" rowspan="1" colspan="1">Follow-up time (months)</th><th align="center" rowspan="1" colspan="1">Long-term mortality (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Greenspon et al.<sup><xref rid="r16" ref-type="bibr">16</xref>]</sup></td><td align="center" rowspan="1" colspan="1">129</td><td align="center" rowspan="1" colspan="1">Percutaneous: 112<break/>Surgery: 17</td><td align="center" rowspan="1" colspan="1">Majors: 4.6<break/>Minors: -</td><td align="center" rowspan="1" colspan="1">10.8</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">14.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Rickard et al.<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup></td><td align="center" rowspan="1" colspan="1">151</td><td align="center" rowspan="1" colspan="1">Percutaneous: 151<break/>Surgery:</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">6.6</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Ipek et al. <sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup></td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">Percutaneous: 28<break/>Surgery: 5</td><td align="center" rowspan="1" colspan="1">Majors: 2.9<break/>Minors: 14.7</td><td align="center" rowspan="1" colspan="1">8.8</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Pichlmaier et al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>&#x000a0;</td><td align="center" rowspan="1" colspan="1">178</td><td align="center" rowspan="1" colspan="1">Percutaneous: 144<break/>Surgery: 34</td><td align="center" rowspan="1" colspan="1">Majors: 2.2<break/>Minors: 14.0</td><td align="center" rowspan="1" colspan="1">3.9</td><td align="center" rowspan="1" colspan="1">Average of 55</td><td align="center" rowspan="1" colspan="1">18.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Knigina et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup></td><td align="center" rowspan="1" colspan="1">192</td><td align="center" rowspan="1" colspan="1">Percutaneous: 155<break/>Surgery: 37</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">3.6</td><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">13.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Grammes et al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup></td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">Percutaneous: 100<break/>Surgery: -</td><td align="center" rowspan="1" colspan="1">Majors: 2.0<break/>Minors: 3.0</td><td align="center" rowspan="1" colspan="1">10.0</td><td align="center" rowspan="1" colspan="1">14.5</td><td align="center" rowspan="1" colspan="1">12.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Tarakji et al.<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup></td><td align="center" rowspan="1" colspan="1">502</td><td align="center" rowspan="1" colspan="1">Percutaneous: 502<break/>Surgery: -</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">5.0</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">20.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Amraoui et al.<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup></td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">Percutaneous: 100<break/>Surgery: 2</td><td align="center" rowspan="1" colspan="1">Majors: 2.0<break/>Minors: 6.0</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">4.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Greenspon et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup></td><td align="center" rowspan="1" colspan="1">145</td><td align="center" rowspan="1" colspan="1">Percutaneous: 145<break/>Surgery: -</td><td align="center" rowspan="1" colspan="1">Majors: 4.8<break/>Minors: -</td><td align="center" rowspan="1" colspan="1">6.2</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">27.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Cengiz et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup></td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">Percutaneous: 17<break/>Surgery: 18</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">3.5</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Baman et al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup></td><td align="center" rowspan="1" colspan="1">210</td><td align="center" rowspan="1" colspan="1">Percutaneous: 170<break/>Surgery: 17</td><td align="center" rowspan="1" colspan="1">Majors: 4.8<break/>Minors:12.3</td><td align="center" rowspan="1" colspan="1">8.1</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">18.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Goya et al.<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup></td><td align="center" rowspan="1" colspan="1">183</td><td align="center" rowspan="1" colspan="1">Percutaneous: 183<break/>Surgery: 4</td><td align="center" rowspan="1" colspan="1">Majors: 2.7<break/>Minors: 3.8</td><td align="center" rowspan="1" colspan="1">2.2</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Deharo et al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup></td><td align="center" rowspan="1" colspan="1">197</td><td align="center" rowspan="1" colspan="1">Percutaneous: 189<break/>Surgery: 13</td><td align="center" rowspan="1" colspan="1">Majors: 1.0<break/>Minors: 12.2</td><td align="center" rowspan="1" colspan="1">4.1</td><td align="center" rowspan="1" colspan="1">Average of 25</td><td align="center" rowspan="1" colspan="1">1 year: 14.3 5 years: 35.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Le et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup></td><td align="center" rowspan="1" colspan="1">416</td><td align="center" rowspan="1" colspan="1">Percutaneous: 325<break/>Surgery: 91</td><td align="center" rowspan="1" colspan="1">Majors: 4.1<break/>Minors: 6.5</td><td align="center" rowspan="1" colspan="1">5.5</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">14.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Gomes et al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup></td><td align="center" rowspan="1" colspan="1">348</td><td align="center" rowspan="1" colspan="1">Percutaneous: 348<break/>Surgery: -</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Tarakji et al.<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup></td><td align="center" rowspan="1" colspan="1">412</td><td align="center" rowspan="1" colspan="1">Percutaneous: 412<break/>Surgery: -</td><td align="center" rowspan="1" colspan="1">Majors: 0.5<break/>Minors: 3.4</td><td align="center" rowspan="1" colspan="1">4.6</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">17.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">3354</td><td align="center" rowspan="1" colspan="1">Percutaneous: 3081<break/>Surgery: 238</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean</td><td align="center" rowspan="1" colspan="1">209.6</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">Majors: 2.9<break/>Minors: 8.4</td><td align="center" rowspan="1" colspan="1">5.4</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">-</td></tr></tbody></table></table-wrap><sec><title>Baseline Characteristics</title><p>The 16 studies included in this systematic review described a total of 3,354
patients diagnosed with CIED-related infection who underwent device removal. The
duration of the selected studies ranged from two to 20 years, with a mean of 8.6
years. The mean age of the evaluated patients was 67.8 years. <xref ref-type="table" rid="t2">Table 2</xref> presents the demographic and
clinical characteristics of the patients analyzed in the studies.</p><p>In the articles by Greenspon et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>, Knigina et
al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>, Greenspon et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup> and Baman et
al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>, infection occurred after review or replacement
of the intracardiac device in 306 out of 676 patients (45.3%). The mean time
from the last procedure to the onset of infection was 29
months<sup>[<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r20" ref-type="bibr">20</xref>-<xref rid="r24" ref-type="bibr">24</xref>]</sup>. In Greenspon et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>, the author
divided the patients into two groups according to time of use of the device,
considering a recent infection as one that occurred within 6 months of the most
recent procedure in the device and a late infection as one that occurred after
six months. Goya et al.<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup> defined a recent infection as one occurring
within three months of the last procedure, a late infection as one occurring
between four and 12 months, and a delayed infection as one that occurred after
12 months. In both studies, most patients had a later infection, namely, 71.8%
and 85.3% of the patients in Greenspon et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. and Goya et
al.<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>, respectively.</p><p>Regarding the types of infected CIED analyzed in the studies, there were 1,745
pacemakers, 819 implantable cardioverter defibrillators (ICD) and 380
biventricular devices with or without defibrillation function.</p></sec><sec><title>Clinical Presentation</title><p>The articles selected for this study characterized the clinical presentation of
patients through the signs and symptoms representative of local infection,
systemic infection, and endocarditis or the identification of vegetations on the
leads or heart valves. The results are shown in <xref ref-type="table" rid="t2">Table 2</xref>.</p><p>The articles by Pichlmaier et al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>, Tarakji et al.<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>, Amraoui et
al.<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>, Baman et al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>, Goya et
al.<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup> and Gomes et al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup> did not describe
the signs and symptoms presented by the patients, classifying the infections
only as local (1,152 patients) or systemic (562 patients).</p><p>The main signs and symptoms of local infection were local purulent drainage,
erythema, pain, swelling, warmth and skin ulceration. The predominant
manifestations of systemic infection were fever, chills, malaise, signs of
sepsis, fatigue, anorexia and nausea.</p><p>The articles described 1,029 patients with endocarditis who were diagnosed by the
modified Duke criteria or the presence of vegetation on echocardiography. The
article by Greenspon et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup> divided the presence of vegetation into two
groups according to their size; the first group included patients with
vegetation smaller than 1 cm, and the second group included patients with
vegetation larger than 1 cm. Patients with smaller vegetation more frequently
showed signs and symptoms of local infection, whereas the presentation of the
systemic infection was more common in patients with larger vegetation.</p><p>In addition, the study by Greenspon et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup> showed that signs of local
infection were seen in most patients with recent infection (onset less than six
months after the last device procedure), which is different from patients with
late infection, who mostly presented signs of systemic infection.</p></sec><sec><title>Device Extraction</title><p>All the selected articles addressed device removal as a treatment of CIED-related
infections. Percutaneous or transvenous extraction was performed in 3,081
patients, and thoracotomy was performed in 238 cases, as shown in <xref ref-type="table" rid="t3">Table 3</xref>.</p><p>The main indications for surgical removal were the failure of transvenous
extraction, large vegetations, vascular trauma in percutaneous extraction, the
need for epicardial leads, concomitant valve involvement, abscesses, and
tricuspid valve stenosis<sup>[<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r20" ref-type="bibr">20</xref>,<xref rid="r25" ref-type="bibr">25</xref>]</sup>.</p><p>In percutaneous extraction, the main technique consisted of simple manual
traction of the cables, but some studies reported the need for more advanced
techniques for proper removal of the device, such as laser sheath (504
patients), locking stylets (323 patients) and dilator sheaths (52
patients)<sup>[<xref rid="r14" ref-type="bibr">14</xref>-<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r24" ref-type="bibr">24</xref>,<xref rid="r25" ref-type="bibr">25</xref>]</sup>. The study by Gomes et
al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup> demonstrated that patients with systemic
infection more commonly required mechanical extraction equipment rather than
simple traction.</p><p>The success rate for the complete removal of infected devices by percutaneous
approach ranged from 83.3% to 97.6%, with a mean of 92.4%<sup>[<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r24" ref-type="bibr">24</xref>,<xref rid="r25" ref-type="bibr">25</xref>]</sup>.</p></sec><sec><title>Complications</title><p>Complications related to lead extraction can be classified as major and
minor<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. Of the 16 evaluated studies, 11 articles
reported the occurrence of complications related to the device extraction
procedure in a total of 191 patients (60 majors and 131 minors). The incidence
of major complications ranged from 0.5% to 4.8%, with a mean of 2.9%. On the
other hand, the incidence of minor complications ranged from 3% to 14.7%, with
an average of 8.4%.</p><p>The major complications presented in the studies were vascular or cardiac rupture
(33.3%), pulmonary embolism (33.3%), cardiac tamponade (10%) and respiratory or
anesthesia-related failure (6.7%). Regarding the minor complications, there was
a predominance of pocket hematoma (31.3%), cable fragment migration or systemic
embolization of vegetations without sequelae (30.5%), the need for blood
transfusion (6.1%), and pericardial effusion without the need for
pericardiocentesis (5.3%).</p><p>Recurrence of infection occurred in 52 patients. In Ipek et al.<sup>[(20]</sup>
study, conservative therapy with only antibiotics or failure to completely
remove the infected device were considered predisposing factors for recurrence
of infection.</p><p>In the study by Greenspon et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>, the presence of larger vegetations was
considered a risk factor for the occurrence of complications, and larger
vegetations were also related to a greater frequency of changes in procedures
for thoracotomy during the device removal attempt.</p></sec><sec><title>Reimplantation</title><p>In the articles used for this systematic review, reimplantation of a new cardiac
electronic device was considered in all patients with clinical indications. The
new procedure was not performed when the patient died, in patients without a
clinical indication or when the patient refused to receive a new device. In
total, reimplants were reported in 1,402 patients. In most articles, the mean
time between the removal of an infected device and the placement of a new device
was within eight to 42 days<sup>[<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r20" ref-type="bibr">20</xref>,<xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r25" ref-type="bibr">25</xref>]</sup>, except in Amraoui et
al.<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>, in which reimplantation of a new epicardial
pacemaker was performed during the same surgical procedure.</p><p>Rickard et al.<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup> observed that patients whose infected
biventricular device was extracted and who were not subsequently reimplanted
with a new device had worse results when compared to those patients who were
reimplanted.</p></sec><sec><title>In-Hospital Mortality</title><p>Mortality during the hospitalization of patients with CIED-related infection
ranged from two to 10.8% in the studies, with an average of 5.4%. The main
identified causes of in-hospital death were sepsis, multiorgan system failure,
severe ventricular dysfunction, stroke, cardiorespiratory arrest, renal failure,
septic shock and acute respiratory failure.</p><p>Greenspon et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup> found no statistically significant correlation
between in-hospital mortality and the size of vegetation presented by patients
with endocarditis associated with intracardiac devices.</p><p>In addition, Knigina et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup> also found no difference in mortality among
the group of patients with recurrent infection compared to the group of patients
with primary infection, i.e., no previous history of infected CIED.</p><p>Finally, Le et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup> observed that patients with complications after
device extraction were four times more likely to die when compared to those with
a successful procedure.</p><p>In this review, the mortality directly related to the CIED extraction procedure
ranged from 0.4% to 3.6%<sup>[<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r25" ref-type="bibr">25</xref>-<xref rid="r27" ref-type="bibr">27</xref>]</sup>.</p></sec><sec><title>Follow-Up and Long-Term Mortality</title><p>In all the surveyed articles that reported follow-up of patients after hospital
admission, the minimum observation time was six months. The mean follow-up time
reported in the studies was 24 months. <xref ref-type="table" rid="t3">Table
3</xref> presents the main characteristics regarding in-hospital and
long-term mortality of the selected studies.</p><p>After six months of follow-up of the patients, some studies observed an average
mortality of 20%<sup>[<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>. Baman et al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup> demonstrated the
following independent factors as predictors of mortality in this period:
systemic embolization, right heart failure, moderate or severe tricuspid
regurgitation and abnormal renal function. The size of the vegetation was not
associated with a worsening of survival in six months<sup>[<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>.</p><p>Regarding mortality after a one-year follow-up, the mean was 14%<sup>[(12
13,24,26,27)]</sup>. In Tarakji et al.<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup> study, the following were listed
as risk factors for mortality within one year after treatment of CIED-related
infections: dementia, chronic renal disease, advanced heart failure, the use of
an anticoagulant, bleeding requiring blood transfusion, simultaneous infection
and systemic infection. The presence of vegetation on echocardiography was not
considered an important risk factor in relation to long-term
mortality<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>.</p><p>In that same study, it was estimated that the presence of systemic infection was
associated with an approximately twice as likely chance of death as the initial
presentation of local infection<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>. In Deharo et al.<sup>[(13]</sup> study,
the one-year mortality rate did not present a statistically significant
difference between the groups with local infection and endocarditis (12.5% and
15.5%, respectively).</p><p>In Le et al.<sup>[(24]</sup> study, factors such as advanced age, greater number
of comorbidities, longer time of cardiac implantation and use of corticosteroids
or immunosuppressive therapy were considered to influence mortality. The author
also showed that patients who did not have their devices removed (because of a
high risk of complications or low life expectancy) presented a higher one-year
mortality rate when compared to patients who had their devices removed. In
addition, in this follow-up period, a three-fold increase in mortality was
observed when the device extraction was delayed<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>.</p><p>In Rickard et al.<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup> paper, it was demonstrated that two years after
the extraction of infected biventricular devices, the survival of patients who
underwent subsequent reimplantation of a new cardiac device was similar to those
who never contracted an implantable device infection. Le et
al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup> also showed lower mortality in the one-year
follow-up period for reimplanted patients compared to those patients who did not
obtain a new device.</p><p>In the article by Knigina et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>, the mean follow-up was 5.5 years (minimum
of 2 years) and the identified mortality was 13.5%. The causes of death were not
related to infection in 92.3% of the cases, and in the remaining patients
(7.7%), septicemia was identified as the cause.</p><p>Deharo et al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup> demonstrated that mortality was 14.3% in one
year and 35.4% in 5 years, but no statistically significant difference in
mortality was found compared to a control group with non-infected CIED. In this
study, advanced age, infected resynchronization device, thrombocytopenia
(platelet count less than 100 Giga/l on admission), renal dysfunction and
reimplantation of an epicardial pacemaker in the right ventricle were predictors
of long-term mortality<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Regarding the treatment of infections related to CIED, all selected studies performed
removal of the infected device, preferably by percutaneous extraction. Surgical
removal was indicated in cases of failure of transvenous extraction, large
vegetations, involvement of valves or lesions that developed during the percutaneous
procedure<sup>[<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r20" ref-type="bibr">20</xref>,<xref rid="r25" ref-type="bibr">25</xref>]</sup>.</p><p>Percutaneous technique has been the preferred method of lead extraction according to
the literature. Although surgical removal presented high mortality rates, it is
important to consider that this type of procedure is associated with severe patients
and complications related to infection or previous procedure, when compared to lower
risk patients submitted to percutaneous lead extraction<sup>[<xref rid="r20" ref-type="bibr">20</xref>-<xref rid="r25" ref-type="bibr">25</xref>]</sup>.</p><p>Prior to the routine use of percutaneous extraction techniques, the infections of the
devices were conservatively treated only with antibiotics. This strategy was
associated with a very high mortality rate, forcing physicians to rethink treatment
options<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>. Grammes et al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup> reported that in nine
retrospective studies, the mortality rate was 41% for patients treated with
antibiotics alone and 19% for patients treated with antibiotic therapy and device
removal. Another study demonstrated that the extraction of the system was related to
better survival after one year (19.9% and 38.2%, respectively, for the groups with
and without extraction)<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>.</p><p>Le et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>
demonstrated an increase in one-year mortality in the minority of patients whose
infected device was not extracted because of the high risk of complications or low
life expectancy and observed a three-fold increase in mortality when delayed
extraction occurred. These data corroborate the current recommendations to extract
the infected device, regardless of local or systemic clinical
presentations<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>.</p><p>The main obstacles to extraction are tissue binding sites along the course of the
lead and the interface between the lead tip and endocardium. In most cases, there is
more than one binding site, and simple traction of the proximal lead is not
transmitted to its distal tip. In these circumstances, there is a significant risk
of rupture of the lead and fibrous tissue, along with all the complications that may
result from rupture<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>.</p><p>With the adoption of new extraction techniques, success rates and safety procedures
have notably improved<sup>[<xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r30" ref-type="bibr">30</xref>,<xref rid="r31" ref-type="bibr">31</xref>]</sup>. In one such technique, a locking stylet inserts
into the lumen of the lead and spreads traction forces along its body to the tip.
Other traction devices include snares, sutures and grasping devices. However, it is
often necessary to use these stylets together with sheaths to directly release the
fibrous tissues<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>.</p><p>Wilkoff et al.<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup> performed a prospective randomized clinical trial
with a sample of 301 patients (PLEXES trial) and verified that the use of a laser
sheath was associated with a better success rate in extraction compared to the group
that did not use this technique (94% and 64%, respectively). In addition, there was
no significant increase in major complications. A further multicenter retrospective
study, Lexicon, which also used laser sheath on lead extraction in a large number of
patients (n=1,449), had a 96.5% removal success rate, and showed major adverse
events in 1.4% of patients, with a mortality of 0.28% related to the
procedure<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup>. Both studies demonstrate the efficacy of the laser
in device extraction, as well as the low rates of complications related to its use.
In the studies analyzed in this review, simple manual traction was used as the main
technique for removal of the device in percutaneous extraction, but other
techniques, such as laser sheath, locking stylets and dilator sheaths, were required
in some cases<sup>[<xref rid="r14" ref-type="bibr">14</xref>-<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r24" ref-type="bibr">24</xref>,<xref rid="r25" ref-type="bibr">25</xref>]</sup>.</p><p>In addition, the studies showed an average success rate of 92.4% in the complete
percutaneous removal of infected devices<sup>[<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r24" ref-type="bibr">24</xref>,<xref rid="r25" ref-type="bibr">25</xref>]</sup>. At the same time, success rates of percutaneous
extraction from 93% to 97% were reported in other large cohorts of
patients<sup>[<xref rid="r32" ref-type="bibr">32</xref>-<xref rid="r34" ref-type="bibr">34</xref>]</sup>. Adequate device extraction is important, as
inadequate device extraction is one of the main predisposing factors for the
recurrence of infection<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>.</p><p>Percutaneous extraction is now accepted as a safe procedure, due to technical and
surgical advances over the years<sup>[<xref rid="r35" ref-type="bibr">35</xref>]</sup>. The percutaneous extraction mortality rates
reported in the literature ranged from 0.1% to 0.6%, and the rate of major
complications ranged from 1.4% to 1.9%<sup>[<xref rid="r33" ref-type="bibr">33</xref>,<xref rid="r34" ref-type="bibr">34</xref>,<xref rid="r36" ref-type="bibr">36</xref>,<xref rid="r37" ref-type="bibr">37</xref>]</sup>. In this review, it was observed that the mortality
associated with the CIED removal procedure ranged from 0.4% to
3.6%<sup>[<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r25" ref-type="bibr">25</xref>-<xref rid="r27" ref-type="bibr">27</xref>]</sup> and that the mean incidence of major complications
was 2.9%, which is a somewhat higher value than those described in the literature.
Only the mortality rates obtained in Pichlmaier et al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup> and Knigina et
al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>
were higher than the overall mortality rate.</p><p>In 191 patients, complications related to the extraction procedures were identified,
of which 60 (31.4%) were major complications and 131 (68.6%) were minor
complications. Le et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup> observed that patients with complications were four
times more likely to die when compared to those with a successful procedure.</p><p>The in-hospital mortality of patients with CIED infection ranged from 2% to 10.8% in
this review, with an average of 5.4%. Grammes et al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup> presented 10%
mortality in the first 30 days after device extraction, but this value did not
reflect mortality directly related to the procedure since it occurred in a subgroup
of critically ill patients with extensive comorbidities. Tarakji et
al.<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup> showed an in-hospital mortality of 25 patients, and
of these, only two (8%) patients died from causes related to device extraction,
which corroborates the idea that postoperative mortality may not reflect
procedure-related mortality.</p><p>Regarding the long-term mortality of these patients, some studies have demonstrated
the following predictors: systemic embolization; moderate to severe tricuspid
regurgitation; and comorbidities, such as chronic renal failure, dementia, advanced
heart failure, presence of signs and symptoms of systemic infection, advanced age,
use of anticoagulants, corticosteroids or immunosuppressive
therapy<sup>[<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r24" ref-type="bibr">24</xref>,<xref rid="r26" ref-type="bibr">26</xref>]</sup>.</p><p>Despite the many advantages of percutaneous extraction, unfortunately this procedure
presents higher costs when compared to surgical removal. Advanced techniques such as
stylets and laser sheath have excessive costs and this is a major limitation of its
use<sup>[<xref rid="r30" ref-type="bibr">30</xref>,<xref rid="r31" ref-type="bibr">31</xref>]</sup>.</p><sec><title>Limitations of the Study</title><p>The authors considered the lack of data standardization in the selected studies
to be a limitation of this review because it is difficult to compare datasets.
Some studies did not present data on procedure-related complications, long-term
mortality, or differences in the results compared to a percutaneous technique
with thoracotomy. Another limitation of was the lack of even comparative studies
between the costs of percutaneous removal versus surgical removal.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>This systematic review revealed the importance of percutaneous extraction of infected
cardiac electronic devices for adequate remission of infection. It also presented
low rates of complications and mortality related to percutaneous removal.</p><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">ASMJR</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work and agreement to be accountable
for all aspects of the work in ensuring that questions related to
the accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TRM</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AOAM</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Escola de Ci&#x000ea;ncias M&#x000e9;dicas,
Farmac&#x000ea;uticas e Biom&#x000e9;dicas of the Pontif&#x000ed;cia Universidade
Cat&#x000f3;lica de Goi&#x000e1;s (PUC-GO), Goi&#x000e2;nia, GO, Brazil.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenspon</surname><given-names>AJ</given-names></name><name><surname>Patel</surname><given-names>JD</given-names></name><name><surname>Lau</surname><given-names>E</given-names></name><name><surname>Ochoa</surname><given-names>JA</given-names></name><name><surname>Frisch</surname><given-names>DR</given-names></name><name><surname>Ho</surname><given-names>RT</given-names></name><etal/></person-group><article-title>Trends in permanent pacemaker implantation in the United States
from 1993 to 2009: increasing complexity of patients and
procedures</article-title><source>J Am Coll Cardiol</source><year>2012</year><volume>60</volume><issue>16</issue><fpage>1540</fpage><lpage>1545</lpage><pub-id pub-id-type="pmid">22999727</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenspon</surname><given-names>AJ</given-names></name><name><surname>Patel</surname><given-names>JD</given-names></name><name><surname>Lau</surname><given-names>E</given-names></name><name><surname>Ochoa</surname><given-names>JA</given-names></name><name><surname>Frisch</surname><given-names>DR</given-names></name><name><surname>Ho</surname><given-names>RT</given-names></name><etal/></person-group><article-title>16-year trends in the infection burden for pacemakers and
implantable cardioverter-defibrillators in the United States 1993 to
2008</article-title><source>J Am Coll Cardiol</source><year>2011</year><volume>58</volume><issue>10</issue><fpage>1001</fpage><lpage>1006</lpage><pub-id pub-id-type="pmid">21867833</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname><given-names>JB</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>OD</given-names></name><name><surname>M&#x000f8;ller</surname><given-names>M</given-names></name><name><surname>Arnsbo</surname><given-names>P</given-names></name><name><surname>Mortensen</surname><given-names>PT</given-names></name><name><surname>Nielsen</surname><given-names>JC</given-names></name></person-group><article-title>Infection after pacemaker implantation: infection rates and risk
factors associated with infection in a population-based cohort study of
46299 consecutive patients</article-title><source>Eur Heart J</source><year>2011</year><volume>32</volume><issue>8</issue><fpage>991</fpage><lpage>998</lpage><pub-id pub-id-type="pmid">21252172</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandoe</surname><given-names>JA</given-names></name><name><surname>Barlow</surname><given-names>G</given-names></name><name><surname>Chambers</surname><given-names>JB</given-names></name><name><surname>Gammage</surname><given-names>M</given-names></name><name><surname>Guleri</surname><given-names>A</given-names></name><name><surname>Howard</surname><given-names>P</given-names></name><etal/><collab>British Society for Antimicrobial Chemotherapy</collab><collab>British Heart Rhythm Society</collab><collab>British Cardiovascular Society</collab><collab>British Heart Valve Society</collab><collab>British Society for Echocardiography</collab></person-group><article-title>Guidelines for the diagnosis, prevention and management of
implantable cardiac electronic device infection. Report of a joint Working
Party project on behalf of the British Society for Antimicrobial
Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS),
British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and
British Society for Echocardiography (BSE)</article-title><source>J Antimicrob Chemother</source><year>2015</year><volume>70</volume><issue>2</issue><fpage>325</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">25355810</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nof</surname><given-names>E</given-names></name><name><surname>Epstein</surname><given-names>LM</given-names></name></person-group><article-title>Complications of cardiac implants: handling device
infections</article-title><source>Eur Heart J</source><year>2013</year><volume>34</volume><issue>3</issue><fpage>229</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">23091204</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habib</surname><given-names>G</given-names></name><name><surname>Lancellotti</surname><given-names>P</given-names></name><name><surname>Antunes</surname><given-names>MJ</given-names></name><name><surname>Bongiorni</surname><given-names>MG</given-names></name><name><surname>Casalta</surname><given-names>JP</given-names></name><name><surname>Del Zotti</surname><given-names>F</given-names></name><etal/><collab>ESC Scientific Document Group</collab></person-group><article-title>2015 ESC Guidelines for the management of infective endocarditis:
The Task Force for the Management of Infective Endocarditis of the European
Society of Cardiology (ESC). Endorsed by: European Association for
Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear
Medicine (EANM)</article-title><source>Eur Heart J</source><year>2015</year><volume>36</volume><issue>44</issue><fpage>3075</fpage><lpage>3128</lpage><pub-id pub-id-type="pmid">26320109</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gib</surname><given-names>MC</given-names></name><name><surname>Alvarez</surname><given-names>JS</given-names></name><name><surname>Wender</surname><given-names>OC</given-names></name></person-group><article-title>Mediastinitis: mortality rate comparing single-stage surgical
approach and preconditioning of wound</article-title><source>Rev Bras Cir Cardiovasc</source><year>2013</year><volume>28</volume><issue>2</issue><fpage>200</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">23939316</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohail</surname><given-names>MR</given-names></name><name><surname>Henrikson</surname><given-names>CA</given-names></name><name><surname>Braid-Forbes</surname><given-names>MJ</given-names></name><name><surname>Forbes</surname><given-names>KF</given-names></name><name><surname>Lerner</surname><given-names>DJ</given-names></name></person-group><article-title>Mortality and cost associated with cardiovascular implantable
electronic device infections</article-title><source>Arch Intern Med</source><year>2011</year><volume>171</volume><issue>20</issue><fpage>1821</fpage><lpage>1828</lpage><pub-id pub-id-type="pmid">21911623</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>J</given-names></name><name><surname>Green</surname><given-names>S</given-names></name></person-group><source>Cochrane handbook for systematic reviews of interventions</source><comment>The Cochrane Collaboration Version 5.1.0</comment><year>2011</year></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkoff</surname><given-names>BL</given-names></name><name><surname>Love</surname><given-names>CJ</given-names></name><name><surname>Byrd</surname><given-names>CL</given-names></name><name><surname>Bongiorni</surname><given-names>MG</given-names></name><name><surname>Carrillo</surname><given-names>RG</given-names></name><name><surname>Crossley</surname><given-names>GH 3rd</given-names></name><etal/><collab>Heart Rhythm Society</collab><collab>American Heart Association</collab></person-group><article-title>Transvenous lead extraction: Heart Rhythm Society expert
consensus on facilities, training, indications, and patient management: this
document was endorsed by the American Heart Association
(AHA)</article-title><source>Heart Rhythm</source><year>2009</year><volume>6</volume><issue>7</issue><fpage>1085</fpage><lpage>1104</lpage><pub-id pub-id-type="pmid">19560098</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Liberati</surname><given-names>A</given-names></name><name><surname>Tetzlaff</surname><given-names>J</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><collab>PRISMA Group</collab></person-group><article-title>Preferred reporting items for systematic reviews and
meta-analyses: the PRISMA statement</article-title><source>PLoS Med</source><year>2009</year><volume>6</volume><issue>7</issue><elocation-id>e1000097</elocation-id><pub-id pub-id-type="pmid">19621072</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amraoui</surname><given-names>S</given-names></name><name><surname>Barandon</surname><given-names>L</given-names></name><name><surname>Whinnett</surname><given-names>Z</given-names></name><name><surname>Ploux</surname><given-names>S</given-names></name><name><surname>Labrousse</surname><given-names>L</given-names></name><name><surname>Denis</surname><given-names>A</given-names></name><etal/></person-group><article-title>Single surgical procedure combining epicardial pacemaker
implantation and subsequent extraction of the infected pacing system for
pacemaker-dependent patients</article-title><source>J Thorac Cardiovasc Surg</source><year>2013</year><volume>146</volume><issue>2</issue><fpage>302</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">22964353</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deharo</surname><given-names>JC</given-names></name><name><surname>Quatre</surname><given-names>A</given-names></name><name><surname>Mancini</surname><given-names>J</given-names></name><name><surname>Khairy</surname><given-names>P</given-names></name><name><surname>Le Dolley</surname><given-names>Y</given-names></name><name><surname>Casalta</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Long-term outcomes following infection of cardiac implantable
electronic devices: a prospective matched cohort study</article-title><source>Heart</source><year>2012</year><volume>98</volume><issue>9</issue><fpage>724</fpage><lpage>731</lpage><pub-id pub-id-type="pmid">22523057</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rickard</surname><given-names>J</given-names></name><name><surname>Tarakji</surname><given-names>K</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name><name><surname>Spragg</surname><given-names>D</given-names></name><name><surname>Cantillon</surname><given-names>DJ</given-names></name><name><surname>Martin</surname><given-names>DO</given-names></name><etal/></person-group><article-title>Survival of patients with biventricular devices after device
infection, extraction, and reimplantation</article-title><source>JACC Heart Fail</source><year>2013</year><volume>1</volume><issue>6</issue><fpage>508</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">24622003</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cengiz</surname><given-names>M</given-names></name><name><surname>Okutucu</surname><given-names>S</given-names></name><name><surname>Ascioglu</surname><given-names>S</given-names></name><name><surname>&#x0015e;ahin</surname><given-names>A</given-names></name><name><surname>Aksoy</surname><given-names>H</given-names></name><name><surname>Sinan Deveci</surname><given-names>O</given-names></name><etal/></person-group><article-title>Permanent pacemaker and implantable cardioverter defibrillator
infections: seven years of diagnostic and therapeutic experience of a single
center</article-title><source>Clin Cardiol</source><year>2010</year><volume>33</volume><issue>7</issue><fpage>406</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">20641117</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenspon</surname><given-names>AJ</given-names></name><name><surname>Le</surname><given-names>KY</given-names></name><name><surname>Prutkin</surname><given-names>JM</given-names></name><name><surname>Sohail</surname><given-names>MR</given-names></name><name><surname>Vikram</surname><given-names>HR</given-names></name><name><surname>Baddour</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Influence of vegetation size on the clinical presentation and
outcome of lead-associated endocarditis: results from the MEDIC
registry</article-title><source>JACC Cardiovasc Imaging</source><year>2014</year><volume>7</volume><issue>6</issue><fpage>541</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">24813965</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knigina</surname><given-names>L</given-names></name><name><surname>K&#x000fc;hn</surname><given-names>C</given-names></name><name><surname>Kutschka</surname><given-names>I</given-names></name><name><surname>Oswald</surname><given-names>H</given-names></name><name><surname>Klein</surname><given-names>G</given-names></name><name><surname>Haverich</surname><given-names>A</given-names></name><etal/></person-group><article-title>Treatment of patients with recurrent or persistent infection of
cardiac implantable electronic devices</article-title><source>Europace</source><year>2010</year><volume>12</volume><issue>9</issue><fpage>1275</fpage><lpage>1281</lpage><pub-id pub-id-type="pmid">20621894</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenspon</surname><given-names>AJ</given-names></name><name><surname>Prutkin</surname><given-names>JM</given-names></name><name><surname>Sohail</surname><given-names>MR</given-names></name><name><surname>Vikram</surname><given-names>HR</given-names></name><name><surname>Baddour</surname><given-names>LM</given-names></name><name><surname>Danik</surname><given-names>SB</given-names></name><etal/></person-group><article-title>Timing of the most recent device procedure influences the
clinical outcome of lead-associated endocarditis results of the MEDIC
(Multicenter Electrophysiologic Device Infection Cohort)</article-title><source>J Am Coll Cardiol</source><year>2012</year><ext-link ext-link-type="uri" xlink:href="59">59</ext-link><issue>7</issue><fpage>681</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">22322085</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baman</surname><given-names>TS</given-names></name><name><surname>Gupta</surname><given-names>SK</given-names></name><name><surname>Valle</surname><given-names>JA</given-names></name><name><surname>Yamada</surname><given-names>E</given-names></name></person-group><article-title>Risk factors for mortality in patients with cardiac
device-related infection</article-title><source>Circ Arrhythm Electrophysiol</source><year>2009</year><volume>2</volume><issue>2</issue><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">19808457</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ipek</surname><given-names>EG</given-names></name><name><surname>Guray</surname><given-names>U</given-names></name><name><surname>Demirkan</surname><given-names>B</given-names></name><name><surname>Guray</surname><given-names>Y</given-names></name><name><surname>Aksu</surname><given-names>T</given-names></name></person-group><article-title>Infections of implantable cardiac rhythm devices: predisposing
factors and outcome</article-title><source>Acta Cardiol</source><year>2012</year><volume>67</volume><issue>3</issue><fpage>303</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">22870738</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grammes</surname><given-names>JA</given-names></name><name><surname>Schulze</surname><given-names>CM</given-names></name><name><surname>Al-Bataineh</surname><given-names>M</given-names></name><name><surname>Yesenosky</surname><given-names>GA</given-names></name><name><surname>Saari</surname><given-names>CS</given-names></name><name><surname>Vrabel</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Percutaneous pacemaker and implantable cardioverter-defibrillator
lead extraction in 100 patients with intracardiac vegetations defined by
transesophageal echocardiogram</article-title><source>J Am Coll Cardiol</source><year>2010</year><volume>55</volume><issue>9</issue><fpage>886</fpage><lpage>894</lpage><pub-id pub-id-type="pmid">20185039</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goya</surname><given-names>M</given-names></name><name><surname>Nagashima</surname><given-names>M</given-names></name><name><surname>Hiroshima</surname><given-names>K</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Makihara</surname><given-names>Y</given-names></name><name><surname>Fukunaga</surname><given-names>M</given-names></name><etal/></person-group><article-title>Lead extractions in patients with cardiac implantable electronic
device infections: single center experience</article-title><source>J Arrhythm</source><year>2016</year><volume>32</volume><issue>4</issue><fpage>308</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">27588155</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>S</given-names></name><name><surname>Cranney</surname><given-names>G</given-names></name><name><surname>Bennett</surname><given-names>M</given-names></name><name><surname>Giles</surname><given-names>R</given-names></name></person-group><article-title>Lead extraction for treatment of cardiac device infection: a
20-year single centre experience</article-title><source>Heart Lung Circ</source><year>2017</year><volume>26</volume><issue>3</issue><fpage>240</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">27614558</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>KY</given-names></name><name><surname>Sohail</surname><given-names>MR</given-names></name><name><surname>Friedman</surname><given-names>PA</given-names></name><name><surname>Uslan</surname><given-names>DZ</given-names></name><name><surname>Cha</surname><given-names>SS</given-names></name><name><surname>Hayes</surname><given-names>DL</given-names></name><etal/><collab>Mayo Cardiovascular Infections Study Group</collab></person-group><article-title>Impact of timing of device removal on mortality in patients with
cardiovascular implantable electronic device infections</article-title><source>Heart Rhythm</source><year>2011</year><volume>8</volume><issue>11</issue><fpage>1678</fpage><lpage>1685</lpage><pub-id pub-id-type="pmid">21699855</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pichlmaier</surname><given-names>M</given-names></name><name><surname>Knigina</surname><given-names>L</given-names></name><name><surname>Kutschka</surname><given-names>I</given-names></name><name><surname>Bara</surname><given-names>C</given-names></name><name><surname>Oswald</surname><given-names>H</given-names></name><name><surname>Klein</surname><given-names>G</given-names></name><etal/></person-group><article-title>Complete removal as a routine treatment for any cardiovascular
implantable electronic device-associated infection</article-title><source>J Thorac Cardiovasc Surg</source><year>2011</year><volume>142</volume><issue>6</issue><fpage>1482</fpage><lpage>1490</lpage><pub-id pub-id-type="pmid">21570093</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarakji</surname><given-names>KG</given-names></name><name><surname>Wazni</surname><given-names>OM</given-names></name><name><surname>Harb</surname><given-names>S</given-names></name><name><surname>Hsu</surname><given-names>A</given-names></name><name><surname>Saliba</surname><given-names>W</given-names></name><name><surname>Wilkoff</surname><given-names>BL</given-names></name></person-group><article-title>Risk factors for 1-year mortality among patients with cardiac
implantable electronic device infection undergoing transvenous lead
extraction: the impact of the infection type and the presence of vegetation
on survival</article-title><source>Europace</source><year>2014</year><volume>16</volume><issue>10</issue><fpage>1490</fpage><lpage>1495</lpage><pub-id pub-id-type="pmid">25087154</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarakji</surname><given-names>KG</given-names></name><name><surname>Chan</surname><given-names>EJ</given-names></name><name><surname>Cantillon</surname><given-names>DJ</given-names></name><name><surname>Doonan</surname><given-names>AL</given-names></name><name><surname>Hu</surname><given-names>T</given-names></name><name><surname>Schmitt</surname><given-names>S</given-names></name><etal/></person-group><article-title>Cardiac implantable electronic device infections: presentation,
management, and patient outcomes</article-title><source>Heart Rhythm</source><year>2010</year><volume>7</volume><issue>8</issue><fpage>1043</fpage><lpage>1047</lpage><pub-id pub-id-type="pmid">20470904</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Athan</surname><given-names>E</given-names></name><name><surname>Chu</surname><given-names>VH</given-names></name><name><surname>Tattevin</surname><given-names>P</given-names></name><name><surname>Selton-Suty</surname><given-names>C</given-names></name><name><surname>Jones</surname><given-names>P</given-names></name><name><surname>Naber</surname><given-names>C</given-names></name><etal/><collab>ICE-PCS Investigators</collab></person-group><article-title>Clinical characteristics and outcome of infective endocarditis
involving implantable cardiac devices</article-title><source>JAMA</source><year>2012</year><volume>307</volume><issue>16</issue><fpage>1727</fpage><lpage>1735</lpage><pub-id pub-id-type="pmid">22535857</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deharo</surname><given-names>JC</given-names></name><name><surname>Bongiorni</surname><given-names>MG</given-names></name><name><surname>Rozkovec</surname><given-names>A</given-names></name><name><surname>Bracke</surname><given-names>F</given-names></name><name><surname>Defaye</surname><given-names>P</given-names></name><name><surname>Fernandez-Lozano</surname><given-names>I</given-names></name><etal/><collab>European Heart Rhythm Association</collab></person-group><article-title>Pathways for training and accreditation for transvenous lead
extraction: a European Heart Rhythm Association position
paper</article-title><source>Europace</source><year>2012</year><volume>14</volume><issue>1</issue><fpage>124</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">22167387</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkoff</surname><given-names>BL</given-names></name><name><surname>Byrd</surname><given-names>CL</given-names></name><name><surname>Love</surname><given-names>CJ</given-names></name><name><surname>Hayes</surname><given-names>DL</given-names></name><name><surname>Sellers</surname><given-names>TD</given-names></name><name><surname>Schaerf</surname><given-names>R</given-names></name><etal/></person-group><article-title>Pacemaker lead extraction with the laser sheath: results of the
pacing lead extraction with the excimer sheath (PLEXES)
trial</article-title><source>J Am Coll Cardiol</source><year>1999</year><volume>33</volume><issue>6</issue><fpage>1671</fpage><lpage>1676</lpage><pub-id pub-id-type="pmid">10334441</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wazni</surname><given-names>O</given-names></name><name><surname>Epstein</surname><given-names>LM</given-names></name><name><surname>Carrillo</surname><given-names>RG</given-names></name><name><surname>Love</surname><given-names>C</given-names></name><name><surname>Adler</surname><given-names>SW</given-names></name><name><surname>Riggio</surname><given-names>DW</given-names></name><etal/></person-group><article-title>Lead extraction in the contemporary setting: the LExICon study:
an observational retrospective study of consecutive laser lead
extractions</article-title><source>J Am Coll Cardiol</source><year>2010</year><volume>55</volume><issue>6</issue><fpage>579</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">20152562</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cacoub</surname><given-names>P</given-names></name><name><surname>Leprince</surname><given-names>P</given-names></name><name><surname>Nataf</surname><given-names>P</given-names></name><name><surname>Hausfater</surname><given-names>P</given-names></name><name><surname>Dorent</surname><given-names>R</given-names></name><name><surname>Wechsler</surname><given-names>B</given-names></name><etal/></person-group><article-title>Pacemaker infective endocarditis</article-title><source>Am J Cardiol</source><year>1998</year><volume>82</volume><issue>4</issue><fpage>480</fpage><lpage>484</lpage><pub-id pub-id-type="pmid">9723637</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrd</surname><given-names>CL</given-names></name><name><surname>Wilkoff</surname><given-names>BL</given-names></name><name><surname>Love</surname><given-names>CJ</given-names></name><name><surname>Sellers</surname><given-names>TD</given-names></name><name><surname>Turk</surname><given-names>KT</given-names></name><name><surname>Reeves</surname><given-names>R</given-names></name><etal/></person-group><article-title>Intravascular extraction of problematic or infected permanent
pacemaker leads: 1994-1996. U.S. Extraction Database, MED
Institute</article-title><source>Pacing Clin Electrophysiol</source><year>1999</year><volume>22</volume><issue>9</issue><fpage>1348</fpage><lpage>1357</lpage><pub-id pub-id-type="pmid">10527016</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>SO 4th</given-names></name><name><surname>Eckart</surname><given-names>RE</given-names></name><name><surname>Albert</surname><given-names>CM</given-names></name><name><surname>Epstein</surname><given-names>LM</given-names></name></person-group><article-title>Large, single-center, single-operator experience with transvenous
lead extraction: outcomes and changing indications</article-title><source>Heart Rhythm</source><year>2008</year><volume>5</volume><issue>4</issue><fpage>520</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">18325849</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Monaco</surname><given-names>A</given-names></name><name><surname>Pelargonio</surname><given-names>G</given-names></name><name><surname>Narducci</surname><given-names>ML</given-names></name><name><surname>Manzoli</surname><given-names>L</given-names></name><name><surname>Boccia</surname><given-names>S</given-names></name><name><surname>Flacco</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Safety of transvenous lead extraction according to centre volume:
a systematic review and meta-analysis</article-title><source>Europace</source><year>2014</year><volume>16</volume><issue>10</issue><fpage>1496</fpage><lpage>1507</lpage><pub-id pub-id-type="pmid">24965015</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>A</given-names></name><name><surname>Wilkoff</surname><given-names>BL</given-names></name></person-group><article-title>Intravascular pacemaker and defibrillator lead extraction: a
state-of-the-art review</article-title><source>Heart Rhythm</source><year>2004</year><volume>1</volume><issue>6</issue><fpage>739</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">15851249</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kantharia</surname><given-names>BK</given-names></name><name><surname>Kutalek</surname><given-names>SP</given-names></name></person-group><article-title>Extraction of pacemaker and implantable cardioverter
defibrillator leads</article-title><source>Curr Opin Cardiol</source><year>1999</year><volume>14</volume><issue>1</issue><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">9932207</pub-id></element-citation></ref></ref-list></back></article>